Stifel Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.51M | Sell |
40,938
-10,308
| -20% | -$1.9M | 0.01% | 1104 |
|
|
2025
Q4 | $9.02M | Buy |
51,246
+13,655
| +36% | +$2.23M | 0.01% | 1011 |
|
|
2025
Q3 | $5.27M | Buy |
37,591
+26,477
| +238% | +$3.58M | ﹤0.01% | 1274 |
|
|
2025
Q2 | $1.4M | Sell |
11,114
-7,962
| -42% | -$992K | ﹤0.01% | 2093 |
|
|
2025
Q1 | $2.61M | Buy |
19,076
+6,320
| +50% | +$903K | ﹤0.01% | 1579 |
|
|
2024
Q4 | $1.95M | Sell |
12,756
-34,798
| -73% | -$5.87M | ﹤0.01% | 1797 |
|
|
2024
Q3 | $9.22M | Buy |
47,554
+868
| +2% | +$182K | 0.01% | 877 |
|
|
2024
Q2 | $10.8M | Sell |
46,686
-12,789
| -22% | -$2.78M | 0.01% | 787 |
|
|
2024
Q1 | $12.8M | Buy |
59,475
+7,827
| +15% | +$1.83M | 0.01% | 714 |
|
|
2023
Q4 | $13.4M | Sell |
51,648
-4,079
| -7% | -$1M | 0.02% | 663 |
|
|
2023
Q3 | $14.3M | Buy |
55,727
+9,809
| +21% | +$2.62M | 0.02% | 586 |
|
|
2023
Q2 | $13.1M | Buy |
45,918
+6,213
| +16% | +$1.85M | 0.02% | 614 |
|
|
2023
Q1 | $11M | Sell |
39,705
-1,831
| -4% | -$507K | 0.02% | 652 |
|
|
2022
Q4 | $11.5M | Buy |
41,536
+5,399
| +15% | +$1.52M | 0.02% | 612 |
|
|
2022
Q3 | $9.65M | Sell |
36,137
-1,939
| -5% | -$412K | 0.02% | 643 |
|
|
2022
Q2 | $7.76M | Sell |
38,076
-6,919
| -15% | -$1.41M | 0.01% | 758 |
|
|
2022
Q1 | $9.48M | Buy |
44,995
+1,170
| +3% | +$254K | 0.01% | 754 |
|
|
2021
Q4 | $10.5M | Sell |
43,825
-3,420
| -7% | -$879K | 0.01% | 719 |
|
|
2021
Q3 | $13.4M | Sell |
47,245
-2,690
| -5% | -$882K | 0.02% | 610 |
|
|
2021
Q2 | $17.3M | Sell |
49,935
-10,336
| -17% | -$3.13M | 0.03% | 509 |
|
|
2021
Q1 | $16.9M | Buy |
60,271
+7,125
| +13% | +$1.92M | 0.03% | 481 |
|
|
2020
Q4 | $13M | Buy |
53,146
+718
| +1% | +$185K | 0.02% | 517 |
|
|
2020
Q3 | $14.9M | Sell |
52,428
-1,818
| -3% | -$507K | 0.03% | 425 |
|
|
2020
Q2 | $14.5M | Sell |
54,246
-2,116
| -4% | -$636K | 0.03% | 401 |
|
|
2020
Q1 | $17.9M | Sell |
56,362
-72,541
| -56% | -$22M | 0.05% | 306 |
|
|
2019
Q4 | $38.2M | Buy |
128,903
+47,591
| +59% | +$13.2M | 0.08% | 244 |
|
|
2019
Q3 | $18.9M | Sell |
81,312
-70,775
| -47% | -$16.5M | 0.05% | 338 |
|
|
2019
Q2 | $35.6M | Sell |
152,087
-32,260
| -17% | -$7.45M | 0.09% | 220 |
|
|
2019
Q1 | $43.5M | Sell |
184,347
-58,595
| -24% | -$18.5M | 0.12% | 196 |
|
|
2018
Q4 | $73.3M | Buy |
242,942
+2,684
| +1% | +$857K | 0.24% | 107 |
|
|
2018
Q3 | $84.7M | Buy |
240,258
+18,603
| +8% | +$6.41M | 0.24% | 100 |
|
|
2018
Q2 | $64.2M | Buy |
221,655
+13,814
| +7% | +$3.88M | 0.2% | 123 |
|
|
2018
Q1 | $56.8M | Buy |
207,841
+18,283
| +10% | +$5.68M | 0.18% | 140 |
|
|
2017
Q4 | $60.5M | Buy |
189,558
+12,464
| +7% | +$4M | 0.19% | 133 |
|
|
2017
Q3 | $55.6M | Buy |
177,094
+28,816
| +19% | +$8.53M | 0.19% | 123 |
|
|
2017
Q2 | $40.2M | Buy |
148,278
+34,992
| +31% | +$9.25M | 0.15% | 156 |
|
|
2017
Q1 | $31M | Buy |
113,286
+11,980
| +12% | +$3.39M | 0.12% | 190 |
|
|
2016
Q4 | $28.7M | Buy |
101,306
+14,715
| +17% | +$4.36M | 0.12% | 187 |
|
|
2016
Q3 | $27.1M | Sell |
86,591
-7,272
| -8% | -$2.15M | 0.12% | 185 |
|
|
2016
Q2 | $22.7M | Sell |
93,863
-10,274
| -10% | -$2.71M | 0.11% | 205 |
|
|
2016
Q1 | $27.1M | Sell |
104,137
-47,529
| -31% | -$12.6M | 0.14% | 159 |
|
|
2015
Q4 | $46.5M | Sell |
151,666
-6
| -0% | -$1.72K | 0.24% | 108 |
|
|
2015
Q3 | $44.3M | Buy |
151,672
+4,156
| +3% | +$1.37M | 0.25% | 103 |
|
|
2015
Q2 | $59.5M | Buy |
147,516
+10,775
| +8% | +$4.32M | 0.31% | 74 |
|
|
2015
Q1 | $57.7M | Sell |
136,741
-14,078
| -9% | -$5.55M | 0.32% | 63 |
|
|
2014
Q4 | $51.2M | Buy |
150,819
+5,736
| +4% | +$1.86M | 0.28% | 80 |
|
|
2014
Q3 | $48M | Sell |
145,083
-1,685
| -1% | -$556K | 0.42% | 36 |
|
|
2014
Q2 | $46.3M | Sell |
146,768
-2,653
| -2% | -$798K | 0.42% | 34 |
|
|
2014
Q1 | $45.7M | Buy |
+149,421
| New | +$47.4M | 0.44% | 33 |
|
Other funds holding BIIB
VCM
VPM
Stifel Financial's BIIB Position: Q1 2026 in Review
Stifel Financial reduced its Biogen (BIIB) stake by 20% in Q1 2026, selling an estimated $1.9M and leaving 40,938 shares worth $7.51M. The position accounts for 0.01% of the portfolio, ranked #1104.
Stifel Financial first reported a position in BIIB in Q1 2014 and has held it in 49 quarters since. The position peaked at $84.7M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Stifel Financial held 40,938 shares of Biogen worth $7.51M as of Q1 2026.
- Stifel Financial sold 10,308 Biogen shares in Q1 2026, an estimated $1.9M.
- Biogen made up 0.01% of Stifel Financial's portfolio in Q1 2026, its #1104 holding.
- Stifel Financial first reported a position in Biogen in Q1 2014 and has held it in 49 quarters since.
- Stifel Financial's Biogen position peaked at $84.7M in Q3 2018.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.